The Elusive Promise of Lenacapavir: Can a New HIV Treatment Overcome Access and Equity Gaps? The introduction of lenacapavir, an injection based medication, has brought renewed hope in the fight against HIV.
This treatment offers an unprecedented solution to adherence issues, requiring only two shots per year compared to daily pill regimens currently in use.
However, its impact will be severely limited if it fails to reach those who need it most.